Skip to main content
Cloudbreak Pharma Inc. logo

Cloudbreak Pharma Inc. — Investor Relations & Filings

Ticker · 2592 HKEX Manufacturing
Filings indexed 71 across all filing types
Latest filing 2025-07-02 Governance Information
Country HK Hong Kong
Listing HKEX 2592

About Cloudbreak Pharma Inc.

https://cloudbreakpharma.com/

Cloudbreak Pharma Inc. is an innovative, clinical-stage ophthalmology biotechnology company dedicated to the research and development of novel and differentiated treatments for chronic eye diseases. The company focuses on improving vision quality globally by developing therapies for both anterior and posterior segment ophthalmic conditions. Its robust pipeline includes products targeting pterygium, pinguecula, meibomian gland dysfunction, glaucoma filtration surgery, age-related macular degeneration, and diabetic retinopathy. Cloudbreak utilizes advanced platforms, including a potent multi-kinase inhibitor formulated as a topical eye drop for anterior segment diseases and a unique Antibody-Drug Synergism Platform for posterior segment diseases.

Recent filings

Filing Released Lang Actions
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
Governance Information Classification · 1% confidence The document is titled "Terms of Reference of the Remuneration Committee" and sets out the committee’s composition, duties, meeting procedures, reporting lines and authority under the corporate governance code. It does not present remuneration amounts or financial data, nor is it simply announcing a report’s publication. Rather, it details internal governance rules, board structure, and committee practices. This fits the definition of Governance Information (CGR).
2025-07-02 English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
Governance Information Classification · 1% confidence The document is the Terms of Reference (charter) of the Company’s Audit Committee, detailing its purpose, composition, authority, duties, and meeting procedures under the Listing Rules. This is a corporate governance document describing internal rules, board structure, and governance practices, which fits the Governance Information category.
2025-07-02 English
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 1% confidence The document is the Third Amended and Restated Memorandum and Articles of Association of Cloudbreak Pharma Inc., setting out the company’s objects, share capital, member liabilities, director definitions and internal governance provisions. These are the constitutional and governance rules of the company, not an announcement of a report or a financial statement, fitting squarely into the Governance Information category.
2025-07-02 English
Documents on Display
Regulatory Filings Classification · 1% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2025-06-24 English
GLOBAL OFFERING
Share Issue/Capital Change Classification · 1% confidence The document is clearly an IPO prospectus outlining the global offering, number of shares to be issued, offer price, underwriting arrangements, application procedures, and expected timetable. It is a full prospectus for a new share issuance rather than a simple announcement or regulatory notice. Therefore it falls under Share Issue/Capital Change (Code: SHA).
2025-06-24 English
GLOBAL OFFERING
Share Issue/Capital Change Classification · 1% confidence The document is a public announcement of Cloudbreak Pharma’s Global Offering (IPO) on the Hong Kong Stock Exchange. It outlines the terms of the share issuance—including number of shares, offer price, underwriting arrangements, application procedures and timetable—representing a new share issue and capital raising. This falls under the Share Issue/Capital Change category.
2025-06-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.